Navigation Links
MAQUET Cardiovascular Launches HEARTSTRING III Proximal Seal System for Coronary Artery Bypass Graft Surgery
Date:4/14/2008

Innovative technology eliminates the need for an aortic clamp reducing the risk for cerebral emboli and potentially improving patient neurocognitive

outcomes

SAN JOSE, Calif., April 14 /PRNewswire/ -- MAQUET Cardiovascular LLC today announced the launch of HEARTSTRING III Proximal Seal System for coronary artery bypass surgery procedures. This latest version of MAQUET's innovative HEARTSTRING proximal seal technology allows surgeons to perform coronary artery bypass grafts without the use of a partial occlusion clamp during beating heart surgery.

"We firmly believe that off-pump beating heart surgery results in better patient outcomes. The HEARTSTRING device provides a means to reduce aortic manipulation, a well-appreciated risk factor for adverse neurologic complications in coronary artery bypass," said John D. Puskas M.D., Chief of Cardiac Surgery at Emory Crawford Long Hospital and Professor of Surgery. "With its unique features and improved delivery system, the new HEARTSTRING III system makes it easier for the cardiac surgeon to perform a clampless proximal anastomosis for either saphenous vein or radial artery conduits."

The HEARTSTRING III system features an improved seal loader and delivery device for fast, easy placement. Once deployed, it maintains a low compliant profile for optimal hemostasis at the anastomotic site. The HEARTSTRING III system enables surgeons to use their own hand-suturing technique for creating a proximal anastomosis with either venous or arterial grafts. With its elegant design and small operational footprint, there is no foreign material left inside the vessel after completion of the anastomosis. The Aortic Cutter makes a single, clean hole in the aorta for graft placement. The HEARTSTRING III system allows for maximum surgical flexibility. Surgeons have the option to perform distal or proximal grafts first and to use grafts of varying lengths, hooded grafts, and angled take-offs.

Mark W. Connolly, M.D., Director of Cardiovascular and Thoracic Surgery at Saint Michael's Medical Center University Heights stated, "St. Michael's is a busy, high-volume institution that performs almost exclusively off-pump, beating heart CABG procedures. The HEARTSTRING III system provides an easy, reliable, and safe means of constructing proximal anastomoses with significantly reduced aortic manipulation. The new seal loader takes HEARTSTRING's user-friendliness to a new level."

"The advancement of our HEARTSTRING product line represents yet another development in our integrated approach to providing innovative surgical solutions for cardiac and vascular surgeons, perfusionists and their teams in order to help patients live better and longer lives," said Patrick Walsh, President of MAQUET Cardiovascular LLC. "As a market leader, MAQUET continues to make significant investment into the field of cardiovascular medicine and we believe the benefits of clampless beating heart surgery are very compelling for the future."

The benefits of clampless beating heart surgery, also known as off-pump coronary artery bypass (OPCAB), include a quicker recovery time, decreased length of hospital stay, less trauma due to the elimination of the heart-lung machine and fewer cognitive and neurological consequences. This is especially important for higher risk individuals who have medical conditions such as diabetes, a history of stroke, or poor physical health.

MAQUET Cardiovascular LLC is a division of MAQUET Medical Systems, part of the publicly listed Swedish group of companies GETINGE AB. MAQUET Cardiovascular was recently formed by combining MAQUET Cardiopulmonary with Boston Scientific's Vascular Surgery and Cardiac Surgery divisions, which includes the products and services of Guidant Cardiac Surgery. The creation of this new organization enables MAQUET to offer a comprehensive array of patient care solutions for less-invasive endoscopic vessel harvesting, off- and on- pump coronary artery bypass surgery, and vascular grafts.

MAQUET has 170 years of healthcare experience, and is committed to becoming "The Gold Standard" for therapeutic medical equipment around the globe. As a market leader, MAQUET offers innovative medical solutions from three divisions: Surgical Workplaces, Critical Care, and Cardiovascular.

MAQUET Medical Systems is headquartered in Rastatt, Germany and employs 4,100 employees, has more than 30 international sales and service subsidiaries, and a network of over 200 dealer distributors worldwide. For more information, please visit http://www.maquet.com and http://www.getinge.com.


'/>"/>
SOURCE MAQUET Cardiovascular LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MAQUET Cardiovascular Announces Patent Infringement Complaints Against Terumo
2. ARJO / Getinge / Maquet Announces New West Coast Showroom Opening
3. Terumo Cardiovascular Systems Responds to Allegations of Patent Infringement
4. Sexual dissatisfaction in postmenopausal women not linked to cardiovascular disease
5. Mary Cheney Joins the Cheney Cardiovascular Institute Board of Directors
6. 2-drug blood pressure therapy lowers cardiovascular risk
7. Decreased sexual satisfaction is not associated with cardiovascular disease in postmenopausal women
8. Mary Matalin and John Ray Join the Cheney Cardiovascular Institute Board of Directors
9. Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACCs 57th Annual Scientific Session
10. Medical Simulation Corporation to Present Comprehensive Cardiac Patient Scenario at the Society for Cardiovascular Angiography and Interventions (SCAI) and American College of Cardiology (ACC) Conference
11. Study finds certain liver disease related to cardiovascular fitness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... CA (PRWEB) , ... February 12, 2016 , ... Donor ... in northern California and Nevada, announced a partnership with San Ramon Regional Medical Center. ... to the hospital’s facilities as a way to accommodate a more certain time frame ...
(Date:2/12/2016)... , ... February 12, 2016 , ... For Coast Dental ... Suzan Sweeney, RDH, and dental assistant Terrell Moore shortly before 7 a.m. to volunteer ... of dental professionals, donating their time and skills to help hundreds of uninsured and ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mediaplanet today announces ... The print component of “Revolutionizing Cancer Care” is distributed within the February 12 ... Seattle, with a circulation of approximately 250,000 copies and an estimated readership of ...
(Date:2/12/2016)... ... February 12, 2016 , ... Atlantic Information Services, ... Plans and PBMs,” an upcoming Feb. 24 webinar that will discuss ways health ... therapeutic categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 ...
(Date:2/12/2016)... San Rafael, CA (PRWEB) , ... February 12, 2016 , ... ... camps outside Des Moines, Iowa. Legacy Golf Club, located in Norwalk, serves as the ... Teacher of the Year, Rob Randall. , “We have had successful camps in recent ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... -- Walgreens has committed to provide drug disposal kiosks ... D.C. as part of a program to combat ... advocacy organization As You Sow. Conrad MacKerron , ... on to unneeded drugs because they lack easily accessible collection ... --> Conrad MacKerron , Senior Vice President at As ...
(Date:2/11/2016)... -- NOIT™ Research LLC, a private, leading-edge autism research group, ... assist needy families in obtaining one of its special ... 10, 2016 and March 31, 2016, the company will ... is an auditory stimulus that plays a key role ... Beth Shier , NOIT Research director. "The ...
(Date:2/11/2016)... Ore. , Feb. 11, 2016 Wellpartner, ... announce the acquisition of SolutionsRx, a full-service 340B company ... Along with providing traditional contract pharmacy services, SolutionsRx also ... clients in navigating the complex 340B regulatory environment. ... --> James R. Love , CEO of ...
Breaking Medicine Technology: